ALTSCHULLER Susan
CIK: 0001817988•Chief Financial Officer
OfficerDirector
Primary company: Cerevel Therapeutics Holdings, Inc. (CERE)
ALTSCHULLER Susan is a corporate insider (Chief Financial Officer) at Cerevel Therapeutics Holdings, Inc. (CERE) filing SEC Form 4 transactions. 19 transactions across 4 companies, totaling $32,071 in purchases and $571,972 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Climb Bio, Inc. CLYM | Award | 600,000 | - | - | 600,000 | 10/1/2025 Filed: 10/1/2025 | Filing → |
Mural Oncology plc MURA | Purchase | 10,000 | $3.21 | $32K | 10,000 | 8/14/2024 Filed: 8/15/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 81,065 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 124,168 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 16,913 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Mural Oncology plc MURA | Award | 8,462 | - | - | 8,462 | 5/30/2024 Filed: 6/5/2024 | Filing → |
Mural Oncology plc MURA | Award | 8,462 | $3.35 | $28K | 8,462 | 5/30/2024 Filed: 6/3/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 81,065 | - | - | 81,065 | 1/19/2024 Filed: 1/23/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Sale | 13,808 | $41.42 | $572K | 16,913 | 12/20/2023 Filed: 12/21/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Exercise | 30,721 | $0.00 | $0 | 0 | 12/19/2023 Filed: 12/21/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Exercise | 30,721 | - | - | 30,721 | 12/19/2023 Filed: 12/21/2023 | Filing → |
Mural Oncology plc MURA | Award | 15,021 | $0.00 | $0 | 15,021 | 12/14/2023 Filed: 12/18/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 30,721 | $0.00 | $0 | 30,721 | 6/1/2023 Filed: 6/5/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 124,168 | $0.00 | $0 | 124,168 | 6/1/2023 Filed: 6/5/2023 | Filing → |
ImmunoGen, Inc. IMGN | Award | 82,500 | $0.00 | $0 | 123,750 | 11/14/2022 Filed: 12/27/2022 | Filing → |
ImmunoGen, Inc. IMGN | Award | 41,250 | $0.00 | $0 | 41,250 | 5/20/2022 Filed: 12/27/2022 | Filing → |
ImmunoGen, Inc. IMGN | Award | 361,568 | $5.32 | $1.92M | 361,568 | 2/4/2022 Filed: 2/8/2022 | Filing → |
ImmunoGen, Inc. IMGN | Award | 163,798 | $7.69 | $1.26M | 163,798 | 2/5/2021 Filed: 2/9/2021 | Filing → |
ImmunoGen, Inc. IMGN | Award | 300,000 | $4.74 | $1.42M | 300,000 | 7/20/2020 Filed: 7/22/2020 | Filing → |
Climb Bio, Inc.
CLYM
Type
Award
Shares
600,000
Price
-
Value
-
Mural Oncology plc
MURA
Type
Purchase
Shares
10,000
Price
$3.21
Value
$32K
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
81,065
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
124,168
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
16,913
Price
-
Value
-
Mural Oncology plc
MURA
Type
Award
Shares
8,462
Price
-
Value
-
Mural Oncology plc
MURA
Type
Award
Shares
8,462
Price
$3.35
Value
$28K
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
81,065
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Sale
Shares
13,808
Price
$41.42
Value
$572K
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Exercise
Shares
30,721
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Exercise
Shares
30,721
Price
-
Value
-
Mural Oncology plc
MURA
Type
Award
Shares
15,021
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
30,721
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
124,168
Price
$0.00
Value
$0
ImmunoGen, Inc.
IMGN
Type
Award
Shares
82,500
Price
$0.00
Value
$0
ImmunoGen, Inc.
IMGN
Type
Award
Shares
41,250
Price
$0.00
Value
$0
ImmunoGen, Inc.
IMGN
Type
Award
Shares
361,568
Price
$5.32
Value
$1.92M
ImmunoGen, Inc.
IMGN
Type
Award
Shares
163,798
Price
$7.69
Value
$1.26M
ImmunoGen, Inc.
IMGN
Type
Award
Shares
300,000
Price
$4.74
Value
$1.42M
AI Agent
Try asking...